“…Pathway inhibitors (labeled in red) include PD98059, wortmannin, LY294002, and the tumor suppressor PTEN (Color figure online) the key involvement of PI3K, ERK 1/2, mitochondrial ATP-potassium channels, and mitochondrial permeability transition pore (mPTP) in reducing myocardial infarct size and myocyte apoptosis during early reperfusion by sevoflurane postconditioning. There has also been a recent report of sevoflurane-induced expansion of human glioma stem cells, with corresponding rises in HIF-1a, HIF-2a, p-AKT, and VEGF [50].…”